Global Malignant Melanoma Drug Market Research Report 2016

November 2016 | 100 pages | ID: G6DDC476CF0EN
QYResearch

Abstracts

Notes:

Production, means the output of Malignant Melanoma Drug

Revenue, means the sales value of Malignant Melanoma Drug

This report studies Malignant Melanoma Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Bristol-Myers Squibb
• Enzon Pharmaceuticals
• Exelixis
• GlaxoSmithKline
• Merck
• Navidea Biopharmaceuticals
• Novartis
• Ono Pharmaceutical
• Pfizer
• Roche

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Malignant Melanoma Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Immunotherapy
• Targeted therapy
• Others

Split by application, this report focuses on consumption, market share and growth rate of Malignant Melanoma Drug in each application, can be divided into

• Hospital use
• Clinic use
• Application 3

Contents

Global Malignant Melanoma Drug Market Research Report 2016

1 MALIGNANT MELANOMA DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Malignant Melanoma Drug
1.2 Malignant Melanoma Drug Segment by Type
  1.2.1 Global Production Market Share of Malignant Melanoma Drug by Type in 2015
Immunotherapy
Targeted therapy
Others
1.3 Malignant Melanoma Drug Segment by Application
  1.3.1 Malignant Melanoma Drug Consumption Market Share by Application in 2015
  1.3.2 Hospital use
  1.3.3 Clinic use
  1.3.4 Application
1.4 Malignant Melanoma Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Malignant Melanoma Drug (2011-2021)

2 GLOBAL MALIGNANT MELANOMA DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Malignant Melanoma Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Malignant Melanoma Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Malignant Melanoma Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Malignant Melanoma Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Malignant Melanoma Drug Market Competitive Situation and Trends
  2.5.1 Malignant Melanoma Drug Market Concentration Rate
  2.5.2 Malignant Melanoma Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL MALIGNANT MELANOMA DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Malignant Melanoma Drug Production and Market Share by Region (2011-2016)
3.2 Global Malignant Melanoma Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL MALIGNANT MELANOMA DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Malignant Melanoma Drug Consumption by Regions (2011-2016)
4.2 North America Malignant Melanoma Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Malignant Melanoma Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Malignant Melanoma Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Malignant Melanoma Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Malignant Melanoma Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Malignant Melanoma Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL MALIGNANT MELANOMA DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Malignant Melanoma Drug Production and Market Share by Type (2011-2016)
5.2 Global Malignant Melanoma Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Malignant Melanoma Drug Price by Type (2011-2016)
5.4 Global Malignant Melanoma Drug Production Growth by Type (2011-2016)

6 GLOBAL MALIGNANT MELANOMA DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Malignant Melanoma Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Malignant Melanoma Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL MALIGNANT MELANOMA DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Bristol-Myers Squibb
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bristol-Myers Squibb Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Enzon Pharmaceuticals
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Enzon Pharmaceuticals Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Exelixis
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Exelixis Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 GlaxoSmithKline Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Merck
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Merck Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Navidea Biopharmaceuticals
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Navidea Biopharmaceuticals Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Novartis
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Novartis Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Ono Pharmaceutical
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Ono Pharmaceutical Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Pfizer
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Pfizer Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Roche
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Malignant Melanoma Drug Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Roche Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 MALIGNANT MELANOMA DRUG MANUFACTURING COST ANALYSIS

8.1 Malignant Melanoma Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Malignant Melanoma Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Malignant Melanoma Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Malignant Melanoma Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MALIGNANT MELANOMA DRUG MARKET FORECAST (2016-2021)

12.1 Global Malignant Melanoma Drug Production, Revenue Forecast (2016-2021)
12.2 Global Malignant Melanoma Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Malignant Melanoma Drug Production Forecast by Type (2016-2021)
12.4 Global Malignant Melanoma Drug Consumption Forecast by Application (2016-2021)
12.5 Malignant Melanoma Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Malignant Melanoma Drug
Figure Global Production Market Share of Malignant Melanoma Drug by Type in 2015
Figure Product Picture of Immunotherapy
Table Major Manufacturers of Immunotherapy
Figure Product Picture of Targeted therapy
Table Major Manufacturers of Targeted therapy
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Malignant Melanoma Drug Consumption Market Share by Application in 2015
Figure Hospital use Examples
Figure Clinic use Examples
Figure Application 3 Examples
Figure North America Malignant Melanoma Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Malignant Melanoma Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Malignant Melanoma Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Malignant Melanoma Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Malignant Melanoma Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Malignant Melanoma Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Malignant Melanoma Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Malignant Melanoma Drug Production of Key Manufacturers (2015 and 2016)
Table Global Malignant Melanoma Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Malignant Melanoma Drug Production Share by Manufacturers
Figure 2016 Malignant Melanoma Drug Production Share by Manufacturers
Table Global Malignant Melanoma Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Malignant Melanoma Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Malignant Melanoma Drug Revenue Share by Manufacturers
Table 2016 Global Malignant Melanoma Drug Revenue Share by Manufacturers
Table Global Market Malignant Melanoma Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Malignant Melanoma Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Malignant Melanoma Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Malignant Melanoma Drug Product Type
Figure Malignant Melanoma Drug Market Share of Top 3 Manufacturers
Figure Malignant Melanoma Drug Market Share of Top 5 Manufacturers
Table Global Malignant Melanoma Drug Production by Regions (2011-2016)
Figure Global Malignant Melanoma Drug Production and Market Share by Regions (2011-2016)
Figure Global Malignant Melanoma Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Malignant Melanoma Drug Production Market Share by Regions
Table Global Malignant Melanoma Drug Revenue by Regions (2011-2016)
Table Global Malignant Melanoma Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Malignant Melanoma Drug Revenue Market Share by Regions
Table Global Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Malignant Melanoma Drug Consumption Market by Regions (2011-2016)
Table Global Malignant Melanoma Drug Consumption Market Share by Regions (2011-2016)
Figure Global Malignant Melanoma Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Malignant Melanoma Drug Consumption Market Share by Regions
Table North America Malignant Melanoma Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Malignant Melanoma Drug Production, Consumption, Import & Export (2011-2016)
Table China Malignant Melanoma Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Malignant Melanoma Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Malignant Melanoma Drug Production, Consumption, Import & Export (2011-2016)
Table India Malignant Melanoma Drug Production, Consumption, Import & Export (2011-2016)
Table Global Malignant Melanoma Drug Production by Type (2011-2016)
Table Global Malignant Melanoma Drug Production Share by Type (2011-2016)
Figure Production Market Share of Malignant Melanoma Drug by Type (2011-2016)
Figure 2015 Production Market Share of Malignant Melanoma Drug by Type
Table Global Malignant Melanoma Drug Revenue by Type (2011-2016)
Table Global Malignant Melanoma Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Malignant Melanoma Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Malignant Melanoma Drug by Type
Table Global Malignant Melanoma Drug Price by Type (2011-2016)
Figure Global Malignant Melanoma Drug Production Growth by Type (2011-2016)
Table Global Malignant Melanoma Drug Consumption by Application (2011-2016)
Table Global Malignant Melanoma Drug Consumption Market Share by Application (2011-2016)
Figure Global Malignant Melanoma Drug Consumption Market Share by Application in 2015
Table Global Malignant Melanoma Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Malignant Melanoma Drug Consumption Growth Rate by Application (2011-2016)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Malignant Melanoma Drug Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Enzon Pharmaceuticals Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Enzon Pharmaceuticals Malignant Melanoma Drug Market Share (2011-2016)
Table Exelixis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Exelixis Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Exelixis Malignant Melanoma Drug Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Malignant Melanoma Drug Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Malignant Melanoma Drug Market Share (2011-2016)
Table Navidea Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Navidea Biopharmaceuticals Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Navidea Biopharmaceuticals Malignant Melanoma Drug Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Malignant Melanoma Drug Market Share (2011-2016)
Table Ono Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ono Pharmaceutical Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Ono Pharmaceutical Malignant Melanoma Drug Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Malignant Melanoma Drug Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Malignant Melanoma Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Malignant Melanoma Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Malignant Melanoma Drug
Figure Manufacturing Process Analysis of Malignant Melanoma Drug
Figure Malignant Melanoma Drug Industrial Chain Analysis
Table Raw Materials Sources of Malignant Melanoma Drug Major Manufacturers in 2015
Table Major Buyers of Malignant Melanoma Drug
Table Distributors/Traders List
Figure Global Malignant Melanoma Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Malignant Melanoma Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Malignant Melanoma Drug Production Forecast by Regions (2016-2021)
Table Global Malignant Melanoma Drug Consumption Forecast by Regions (2016-2021)
Table Global Malignant Melanoma Drug Production Forecast by Type (2016-2021)
Table Global Malignant Melanoma Drug Consumption Forecast by Application (2016-2021)